Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
TLS in Tumors: What Lies Within
Catherine Sautès-Fridman1, Wolf Herman Fridman1
1INSERM, UMR_S 1138, Cordeliers Research Center, F-75006, Paris, France; University Paris Descartes, Sorbonne Paris Cité, UMR_S 1138, Cordeliers Research Center, F-75006, Paris, France; UPMC University Paris 06, Sorbonne Universités, UMR_S 1138, Cordeliers Research Center, F-75006, Paris, France.
Tertiary lymphoid structures (TLS) in tumors play a dual role. These sites can harbor regulatory T cells and serve as niches for tumor progenitor cells, potentially influencing cancer recurrence.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Tertiary lymphoid structures (TLS) are increasingly recognized for their role in cancer immunity.
- Recent studies using mouse models are shedding new light on the complex functions of TLS in various cancers.
Purpose of the Study:
- To investigate the role of regulatory T (Treg) cell infiltration and functional heterogeneity within TLS in lung tumors.
- To explore how inflammation-associated TLS act as niches for tumor progenitor cells, potentially contributing to hepatocellular carcinoma recurrence.
Main Methods:
- Utilized mouse models to study TLS in lung tumors.
- Examined Treg cell infiltration and heterogeneity within TLS.
- Investigated the role of inflammation-associated TLS in hepatocellular carcinoma.
Main Results:
- Joshi et al. detailed Treg cell infiltration and functional diversity in TLS within lung tumors.
- Finkin et al. found that inflammation-associated TLS can serve as niches for tumor progenitor cells.
- These findings suggest TLS can influence tumor progression and recurrence.
Conclusions:
- TLS exhibit complex roles in cancer, influencing immune cell activity and tumor cell behavior.
- Understanding TLS dynamics is crucial for developing novel cancer therapies.
- TLS may represent a therapeutic target for preventing cancer recurrence, particularly in hepatocellular carcinoma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...

